Literature DB >> 15117792

Reliability of symptoms to determine use of bone scans to identify bone metastases in lung cancer: prospective study.

Martin Hetzel1, Juergen Hetzel, Coskun Arslandemir, Karin Nüssle, Holger Schirrmeister.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15117792      PMCID： PMC403846          DOI： 10.1136/bmj.328.7447.1051

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

2.  Descriptive epidemiology of low-back pain and its related medical care in the United States.

Authors:  R A Deyo; Y J Tsui-Wu
Journal:  Spine (Phila Pa 1976)       Date:  1987-04       Impact factor: 3.468

3.  Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning.

Authors:  F Michel; M Solèr; E Imhof; A P Perruchoud
Journal:  Thorax       Date:  1991-07       Impact factor: 9.139

4.  The noninvasive staging of non-small cell lung cancer: the guidelines.

Authors:  Gerard A Silvestri; Lynn T Tanoue; Mitchell L Margolis; John Barker; Frank Detterbeck
Journal:  Chest       Date:  2003-01       Impact factor: 9.410
  4 in total
  8 in total

1.  Bone scanning in lung cancer: evidence is not sufficient to justify routine bone scanning.

Authors:  Rachel E Benamore; James J Entwisle; Mick D Peake
Journal:  BMJ       Date:  2004-07-24

2.  Bone scanning in lung cancer: pretest probability is of value.

Authors:  Fabio Puglisi
Journal:  BMJ       Date:  2004-07-24

Review 3.  [MRI in staging of lung cancer].

Authors:  C Hintze; J Biederer; H W Wenz; R Eberhardt; H U Kauczor
Journal:  Radiologe       Date:  2006-04       Impact factor: 0.635

Review 4.  Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.

Authors:  Laura Evangelista; Francesco Bertoldo; Francesco Boccardo; Giario Conti; Ilario Menchi; Francesco Mungai; Umberto Ricardi; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-09       Impact factor: 9.236

5.  Can clinical factors be determinants of bone metastases in non-small cell lung cancer?

Authors:  Ahmet Ursavas; Mehmet Karadag; Esra Uzaslan; Erkan Rodoplu; Ezgi Demirdögen; Basak Burgazlioglu; R Oktay Gozu
Journal:  Ann Thorac Med       Date:  2007-01       Impact factor: 2.219

6.  Is there any significance of lung cancer histology to compare the diagnostic accuracies of (18)F-FDG-PET/CT and (99m)Tc-MDP BS for the detection of bone metastases in advanced NSCLC?

Authors:  Ali Inal; Muhammed Ali Kaplan; Mehmet Kucukoner; Zuhat Urakcı; Zeki Dostbil; Hail Komek; Hakan Onder; Bekir Tasdemir; Abdurrahman Isıkdogan
Journal:  Contemp Oncol (Pozn)       Date:  2014-06-03

7.  Is 99m Tc bone scintigraphy necessary in the preoperative workup for patients with cT1N0 subsolid lung cancer? A prospective multicenter cohort study.

Authors:  Hang Li; Ting Ye; Nan Li; Guozhan Xia; Bin Li; Yang Zhang; Hong Hu; Yihua Sun; Yawei Zhang; Jiaqing Xiang; Dongchun Ma; Yuan Weng; Shilei Liu; Chunyi Jia; Bin Qian; Yajia Gu; Yuan Li; Shaoli Song; Haiquan Chen
Journal:  Thorac Cancer       Date:  2020-11-19       Impact factor: 3.500

8.  When Should ⁹⁹mTc Bone Scintigraphy Be Performed in cT1N0 Non-Small Cell Lung Cancer Patients?

Authors:  Hang Li; Hong Hu; Rui Wang; Yawei Zhang; Jiaqing Xiang; Quan Liu; Wei Shi; Yihua Sun; Haiquan Chen
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.